Absorption and disposition kinetics of 3,3',4,4'- tetrachloroazoxybenzene in the male Fischer 344 rat

T. L. Ziegler, U. A. Pillai, R. L. Smith, M. J. Kattnig, D. C. Liebler, Michael Mayersohn, I. G. Sipes

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

3,3',4,4'-Tetrachloroazoxybenzene (TCAOB) is a structural analog of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). It is formed as a byproduct during the synthesis of industrial products such as herbicides. TCAOB is a ligand for the Ah receptor and, at much higher doses, exhibits toxicities similar to TCDD. Although the reduced in vivo toxicity of TCAOB probably reflects differences in disposition, this study characterized its absorption and disposition kinetics. Male Fischer 344 rats were administered [ 14C]TCAOB (3.4 or 34 mg/kg po, 3.4 mg/kg iv), and the excretion of the radiolabel was monitored over 96 hr. After the low and high dose, 35% and 30% of the [ 14C]TCAOB were eliminated in the urine, with 55% and 54% eliminated in the faces. At 96 hr, the adipose tissue:blood ratios of [ 14C]TCAOB equivalents were 8 and 26 for the low and high doses, respectively. After the intravenous dose of TCAOB, the adipose tissue:blood ratio was 21 at 96 hr. Other tissue:blood ratios were of little significance (0.06-3.2). Pharmacokinetic parameters indicate that the parent molecule is cleared from blood with an average half-life of 7 hr and an average clearance of 11 ml/min · kg. Absolute bioavailability was calculated to be ~9%. Urine contained a variety of dichlorolaniline conjugates, which support the importance of azo reduction in the disposition of TCAOB. When compared with TCDD, the absorption of TCAOB is greatly reduced and the elimination of metabolites greatly enhanced. Therefore, at equal molar oral doses, TCAOB would express lower levels of Ah receptor-mediated toxicity than those defined for TCDD.

Original languageEnglish (US)
Pages (from-to)1009-1014
Number of pages6
JournalDrug Metabolism and Disposition
Volume24
Issue number9
StatePublished - Sep 1996

Fingerprint

Inbred F344 Rats
Rats
Blood
Toxicity
Kinetics
Tissue
Adipose Tissue
Urine
Pharmacokinetics
Herbicides
Metabolites
Biological Availability
Byproducts
Half-Life
Ligands
Molecules
1,4-dioxin
Polychlorinated Dibenzodioxins

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Ziegler, T. L., Pillai, U. A., Smith, R. L., Kattnig, M. J., Liebler, D. C., Mayersohn, M., & Sipes, I. G. (1996). Absorption and disposition kinetics of 3,3',4,4'- tetrachloroazoxybenzene in the male Fischer 344 rat. Drug Metabolism and Disposition, 24(9), 1009-1014.

Absorption and disposition kinetics of 3,3',4,4'- tetrachloroazoxybenzene in the male Fischer 344 rat. / Ziegler, T. L.; Pillai, U. A.; Smith, R. L.; Kattnig, M. J.; Liebler, D. C.; Mayersohn, Michael; Sipes, I. G.

In: Drug Metabolism and Disposition, Vol. 24, No. 9, 09.1996, p. 1009-1014.

Research output: Contribution to journalArticle

Ziegler, TL, Pillai, UA, Smith, RL, Kattnig, MJ, Liebler, DC, Mayersohn, M & Sipes, IG 1996, 'Absorption and disposition kinetics of 3,3',4,4'- tetrachloroazoxybenzene in the male Fischer 344 rat', Drug Metabolism and Disposition, vol. 24, no. 9, pp. 1009-1014.
Ziegler, T. L. ; Pillai, U. A. ; Smith, R. L. ; Kattnig, M. J. ; Liebler, D. C. ; Mayersohn, Michael ; Sipes, I. G. / Absorption and disposition kinetics of 3,3',4,4'- tetrachloroazoxybenzene in the male Fischer 344 rat. In: Drug Metabolism and Disposition. 1996 ; Vol. 24, No. 9. pp. 1009-1014.
@article{ae6477fa6cd04debb2680da129fbf85e,
title = "Absorption and disposition kinetics of 3,3',4,4'- tetrachloroazoxybenzene in the male Fischer 344 rat",
abstract = "3,3',4,4'-Tetrachloroazoxybenzene (TCAOB) is a structural analog of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). It is formed as a byproduct during the synthesis of industrial products such as herbicides. TCAOB is a ligand for the Ah receptor and, at much higher doses, exhibits toxicities similar to TCDD. Although the reduced in vivo toxicity of TCAOB probably reflects differences in disposition, this study characterized its absorption and disposition kinetics. Male Fischer 344 rats were administered [ 14C]TCAOB (3.4 or 34 mg/kg po, 3.4 mg/kg iv), and the excretion of the radiolabel was monitored over 96 hr. After the low and high dose, 35{\%} and 30{\%} of the [ 14C]TCAOB were eliminated in the urine, with 55{\%} and 54{\%} eliminated in the faces. At 96 hr, the adipose tissue:blood ratios of [ 14C]TCAOB equivalents were 8 and 26 for the low and high doses, respectively. After the intravenous dose of TCAOB, the adipose tissue:blood ratio was 21 at 96 hr. Other tissue:blood ratios were of little significance (0.06-3.2). Pharmacokinetic parameters indicate that the parent molecule is cleared from blood with an average half-life of 7 hr and an average clearance of 11 ml/min · kg. Absolute bioavailability was calculated to be ~9{\%}. Urine contained a variety of dichlorolaniline conjugates, which support the importance of azo reduction in the disposition of TCAOB. When compared with TCDD, the absorption of TCAOB is greatly reduced and the elimination of metabolites greatly enhanced. Therefore, at equal molar oral doses, TCAOB would express lower levels of Ah receptor-mediated toxicity than those defined for TCDD.",
author = "Ziegler, {T. L.} and Pillai, {U. A.} and Smith, {R. L.} and Kattnig, {M. J.} and Liebler, {D. C.} and Michael Mayersohn and Sipes, {I. G.}",
year = "1996",
month = "9",
language = "English (US)",
volume = "24",
pages = "1009--1014",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "9",

}

TY - JOUR

T1 - Absorption and disposition kinetics of 3,3',4,4'- tetrachloroazoxybenzene in the male Fischer 344 rat

AU - Ziegler, T. L.

AU - Pillai, U. A.

AU - Smith, R. L.

AU - Kattnig, M. J.

AU - Liebler, D. C.

AU - Mayersohn, Michael

AU - Sipes, I. G.

PY - 1996/9

Y1 - 1996/9

N2 - 3,3',4,4'-Tetrachloroazoxybenzene (TCAOB) is a structural analog of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). It is formed as a byproduct during the synthesis of industrial products such as herbicides. TCAOB is a ligand for the Ah receptor and, at much higher doses, exhibits toxicities similar to TCDD. Although the reduced in vivo toxicity of TCAOB probably reflects differences in disposition, this study characterized its absorption and disposition kinetics. Male Fischer 344 rats were administered [ 14C]TCAOB (3.4 or 34 mg/kg po, 3.4 mg/kg iv), and the excretion of the radiolabel was monitored over 96 hr. After the low and high dose, 35% and 30% of the [ 14C]TCAOB were eliminated in the urine, with 55% and 54% eliminated in the faces. At 96 hr, the adipose tissue:blood ratios of [ 14C]TCAOB equivalents were 8 and 26 for the low and high doses, respectively. After the intravenous dose of TCAOB, the adipose tissue:blood ratio was 21 at 96 hr. Other tissue:blood ratios were of little significance (0.06-3.2). Pharmacokinetic parameters indicate that the parent molecule is cleared from blood with an average half-life of 7 hr and an average clearance of 11 ml/min · kg. Absolute bioavailability was calculated to be ~9%. Urine contained a variety of dichlorolaniline conjugates, which support the importance of azo reduction in the disposition of TCAOB. When compared with TCDD, the absorption of TCAOB is greatly reduced and the elimination of metabolites greatly enhanced. Therefore, at equal molar oral doses, TCAOB would express lower levels of Ah receptor-mediated toxicity than those defined for TCDD.

AB - 3,3',4,4'-Tetrachloroazoxybenzene (TCAOB) is a structural analog of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). It is formed as a byproduct during the synthesis of industrial products such as herbicides. TCAOB is a ligand for the Ah receptor and, at much higher doses, exhibits toxicities similar to TCDD. Although the reduced in vivo toxicity of TCAOB probably reflects differences in disposition, this study characterized its absorption and disposition kinetics. Male Fischer 344 rats were administered [ 14C]TCAOB (3.4 or 34 mg/kg po, 3.4 mg/kg iv), and the excretion of the radiolabel was monitored over 96 hr. After the low and high dose, 35% and 30% of the [ 14C]TCAOB were eliminated in the urine, with 55% and 54% eliminated in the faces. At 96 hr, the adipose tissue:blood ratios of [ 14C]TCAOB equivalents were 8 and 26 for the low and high doses, respectively. After the intravenous dose of TCAOB, the adipose tissue:blood ratio was 21 at 96 hr. Other tissue:blood ratios were of little significance (0.06-3.2). Pharmacokinetic parameters indicate that the parent molecule is cleared from blood with an average half-life of 7 hr and an average clearance of 11 ml/min · kg. Absolute bioavailability was calculated to be ~9%. Urine contained a variety of dichlorolaniline conjugates, which support the importance of azo reduction in the disposition of TCAOB. When compared with TCDD, the absorption of TCAOB is greatly reduced and the elimination of metabolites greatly enhanced. Therefore, at equal molar oral doses, TCAOB would express lower levels of Ah receptor-mediated toxicity than those defined for TCDD.

UR - http://www.scopus.com/inward/record.url?scp=0029832999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029832999&partnerID=8YFLogxK

M3 - Article

C2 - 8886612

AN - SCOPUS:0029832999

VL - 24

SP - 1009

EP - 1014

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 9

ER -